Global Radiopharmaceutical Therapy Market Research Report 2024(Status and Outlook)
Report Overview:
The Global Radiopharmaceutical Therapy Market Size was estimated at USD 7012.98 million in 2023 and is projected to reach USD 8822.59 million by 2029, exhibiting a CAGR of 3.90% during the forecast period.
This report provides a deep insight into the global Radiopharmaceutical Therapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Radiopharmaceutical Therapy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Radiopharmaceutical Therapy market in any manner.
Global Radiopharmaceutical Therapy Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Bracco Imaging
Bayer
Mallinckrodt
Nordion
Triad Isotopes
Lantheus
IBA Group
GE Healthcare
China Isotope & Radiation
Jubilant Pharma
Eli Lilly
Advanced Accelerator Applications
SIEMENS
Dongcheng
Navidea
Market Segmentation (by Type)
Actinium-225
Lutetium-177
Radium-223
Holmium-166
Other
Market Segmentation (by Application)
Oncology
Cardiology
Other
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Radiopharmaceutical Therapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
The Global Radiopharmaceutical Therapy Market Size was estimated at USD 7012.98 million in 2023 and is projected to reach USD 8822.59 million by 2029, exhibiting a CAGR of 3.90% during the forecast period.
This report provides a deep insight into the global Radiopharmaceutical Therapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Radiopharmaceutical Therapy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Radiopharmaceutical Therapy market in any manner.
Global Radiopharmaceutical Therapy Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Bracco Imaging
Bayer
Mallinckrodt
Nordion
Triad Isotopes
Lantheus
IBA Group
GE Healthcare
China Isotope & Radiation
Jubilant Pharma
Eli Lilly
Advanced Accelerator Applications
SIEMENS
Dongcheng
Navidea
Market Segmentation (by Type)
Actinium-225
Lutetium-177
Radium-223
Holmium-166
Other
Market Segmentation (by Application)
Oncology
Cardiology
Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Radiopharmaceutical Therapy Market
- Overview of the regional outlook of the Radiopharmaceutical Therapy Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Radiopharmaceutical Therapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Radiopharmaceutical Therapy
1.2 Key Market Segments
1.2.1 Radiopharmaceutical Therapy Segment by Type
1.2.2 Radiopharmaceutical Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 RADIOPHARMACEUTICAL THERAPY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Radiopharmaceutical Therapy Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Radiopharmaceutical Therapy Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 RADIOPHARMACEUTICAL THERAPY MARKET COMPETITIVE LANDSCAPE
3.1 Global Radiopharmaceutical Therapy Sales by Manufacturers (2019-2024)
3.2 Global Radiopharmaceutical Therapy Revenue Market Share by Manufacturers (2019-2024)
3.3 Radiopharmaceutical Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Radiopharmaceutical Therapy Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Radiopharmaceutical Therapy Sales Sites, Area Served, Product Type
3.6 Radiopharmaceutical Therapy Market Competitive Situation and Trends
3.6.1 Radiopharmaceutical Therapy Market Concentration Rate
3.6.2 Global 5 and 10 Largest Radiopharmaceutical Therapy Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 RADIOPHARMACEUTICAL THERAPY INDUSTRY CHAIN ANALYSIS
4.1 Radiopharmaceutical Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF RADIOPHARMACEUTICAL THERAPY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 RADIOPHARMACEUTICAL THERAPY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Radiopharmaceutical Therapy Sales Market Share by Type (2019-2024)
6.3 Global Radiopharmaceutical Therapy Market Size Market Share by Type (2019-2024)
6.4 Global Radiopharmaceutical Therapy Price by Type (2019-2024)
7 RADIOPHARMACEUTICAL THERAPY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Radiopharmaceutical Therapy Market Sales by Application (2019-2024)
7.3 Global Radiopharmaceutical Therapy Market Size (M USD) by Application (2019-2024)
7.4 Global Radiopharmaceutical Therapy Sales Growth Rate by Application (2019-2024)
8 RADIOPHARMACEUTICAL THERAPY MARKET SEGMENTATION BY REGION
8.1 Global Radiopharmaceutical Therapy Sales by Region
8.1.1 Global Radiopharmaceutical Therapy Sales by Region
8.1.2 Global Radiopharmaceutical Therapy Sales Market Share by Region
8.2 North America
8.2.1 North America Radiopharmaceutical Therapy Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Radiopharmaceutical Therapy Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Radiopharmaceutical Therapy Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Radiopharmaceutical Therapy Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Radiopharmaceutical Therapy Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Bracco Imaging
9.1.1 Bracco Imaging Radiopharmaceutical Therapy Basic Information
9.1.2 Bracco Imaging Radiopharmaceutical Therapy Product Overview
9.1.3 Bracco Imaging Radiopharmaceutical Therapy Product Market Performance
9.1.4 Bracco Imaging Business Overview
9.1.5 Bracco Imaging Radiopharmaceutical Therapy SWOT Analysis
9.1.6 Bracco Imaging Recent Developments
9.2 Bayer
9.2.1 Bayer Radiopharmaceutical Therapy Basic Information
9.2.2 Bayer Radiopharmaceutical Therapy Product Overview
9.2.3 Bayer Radiopharmaceutical Therapy Product Market Performance
9.2.4 Bayer Business Overview
9.2.5 Bayer Radiopharmaceutical Therapy SWOT Analysis
9.2.6 Bayer Recent Developments
9.3 Mallinckrodt
9.3.1 Mallinckrodt Radiopharmaceutical Therapy Basic Information
9.3.2 Mallinckrodt Radiopharmaceutical Therapy Product Overview
9.3.3 Mallinckrodt Radiopharmaceutical Therapy Product Market Performance
9.3.4 Mallinckrodt Radiopharmaceutical Therapy SWOT Analysis
9.3.5 Mallinckrodt Business Overview
9.3.6 Mallinckrodt Recent Developments
9.4 Nordion
9.4.1 Nordion Radiopharmaceutical Therapy Basic Information
9.4.2 Nordion Radiopharmaceutical Therapy Product Overview
9.4.3 Nordion Radiopharmaceutical Therapy Product Market Performance
9.4.4 Nordion Business Overview
9.4.5 Nordion Recent Developments
9.5 Triad Isotopes
9.5.1 Triad Isotopes Radiopharmaceutical Therapy Basic Information
9.5.2 Triad Isotopes Radiopharmaceutical Therapy Product Overview
9.5.3 Triad Isotopes Radiopharmaceutical Therapy Product Market Performance
9.5.4 Triad Isotopes Business Overview
9.5.5 Triad Isotopes Recent Developments
9.6 Lantheus
9.6.1 Lantheus Radiopharmaceutical Therapy Basic Information
9.6.2 Lantheus Radiopharmaceutical Therapy Product Overview
9.6.3 Lantheus Radiopharmaceutical Therapy Product Market Performance
9.6.4 Lantheus Business Overview
9.6.5 Lantheus Recent Developments
9.7 IBA Group
9.7.1 IBA Group Radiopharmaceutical Therapy Basic Information
9.7.2 IBA Group Radiopharmaceutical Therapy Product Overview
9.7.3 IBA Group Radiopharmaceutical Therapy Product Market Performance
9.7.4 IBA Group Business Overview
9.7.5 IBA Group Recent Developments
9.8 GE Healthcare
9.8.1 GE Healthcare Radiopharmaceutical Therapy Basic Information
9.8.2 GE Healthcare Radiopharmaceutical Therapy Product Overview
9.8.3 GE Healthcare Radiopharmaceutical Therapy Product Market Performance
9.8.4 GE Healthcare Business Overview
9.8.5 GE Healthcare Recent Developments
9.9 China Isotope and Radiation
9.9.1 China Isotope and Radiation Radiopharmaceutical Therapy Basic Information
9.9.2 China Isotope and Radiation Radiopharmaceutical Therapy Product Overview
9.9.3 China Isotope and Radiation Radiopharmaceutical Therapy Product Market Performance
9.9.4 China Isotope and Radiation Business Overview
9.9.5 China Isotope and Radiation Recent Developments
9.10 Jubilant Pharma
9.10.1 Jubilant Pharma Radiopharmaceutical Therapy Basic Information
9.10.2 Jubilant Pharma Radiopharmaceutical Therapy Product Overview
9.10.3 Jubilant Pharma Radiopharmaceutical Therapy Product Market Performance
9.10.4 Jubilant Pharma Business Overview
9.10.5 Jubilant Pharma Recent Developments
9.11 Eli Lilly
9.11.1 Eli Lilly Radiopharmaceutical Therapy Basic Information
9.11.2 Eli Lilly Radiopharmaceutical Therapy Product Overview
9.11.3 Eli Lilly Radiopharmaceutical Therapy Product Market Performance
9.11.4 Eli Lilly Business Overview
9.11.5 Eli Lilly Recent Developments
9.12 Advanced Accelerator Applications
9.12.1 Advanced Accelerator Applications Radiopharmaceutical Therapy Basic Information
9.12.2 Advanced Accelerator Applications Radiopharmaceutical Therapy Product Overview
9.12.3 Advanced Accelerator Applications Radiopharmaceutical Therapy Product Market Performance
9.12.4 Advanced Accelerator Applications Business Overview
9.12.5 Advanced Accelerator Applications Recent Developments
9.13 SIEMENS
9.13.1 SIEMENS Radiopharmaceutical Therapy Basic Information
9.13.2 SIEMENS Radiopharmaceutical Therapy Product Overview
9.13.3 SIEMENS Radiopharmaceutical Therapy Product Market Performance
9.13.4 SIEMENS Business Overview
9.13.5 SIEMENS Recent Developments
9.14 Dongcheng
9.14.1 Dongcheng Radiopharmaceutical Therapy Basic Information
9.14.2 Dongcheng Radiopharmaceutical Therapy Product Overview
9.14.3 Dongcheng Radiopharmaceutical Therapy Product Market Performance
9.14.4 Dongcheng Business Overview
9.14.5 Dongcheng Recent Developments
9.15 Navidea
9.15.1 Navidea Radiopharmaceutical Therapy Basic Information
9.15.2 Navidea Radiopharmaceutical Therapy Product Overview
9.15.3 Navidea Radiopharmaceutical Therapy Product Market Performance
9.15.4 Navidea Business Overview
9.15.5 Navidea Recent Developments
10 RADIOPHARMACEUTICAL THERAPY MARKET FORECAST BY REGION
10.1 Global Radiopharmaceutical Therapy Market Size Forecast
10.2 Global Radiopharmaceutical Therapy Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Radiopharmaceutical Therapy Market Size Forecast by Country
10.2.3 Asia Pacific Radiopharmaceutical Therapy Market Size Forecast by Region
10.2.4 South America Radiopharmaceutical Therapy Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Radiopharmaceutical Therapy by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Radiopharmaceutical Therapy Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Radiopharmaceutical Therapy by Type (2025-2030)
11.1.2 Global Radiopharmaceutical Therapy Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Radiopharmaceutical Therapy by Type (2025-2030)
11.2 Global Radiopharmaceutical Therapy Market Forecast by Application (2025-2030)
11.2.1 Global Radiopharmaceutical Therapy Sales (Kilotons) Forecast by Application
11.2.2 Global Radiopharmaceutical Therapy Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Radiopharmaceutical Therapy
1.2 Key Market Segments
1.2.1 Radiopharmaceutical Therapy Segment by Type
1.2.2 Radiopharmaceutical Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 RADIOPHARMACEUTICAL THERAPY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Radiopharmaceutical Therapy Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Radiopharmaceutical Therapy Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 RADIOPHARMACEUTICAL THERAPY MARKET COMPETITIVE LANDSCAPE
3.1 Global Radiopharmaceutical Therapy Sales by Manufacturers (2019-2024)
3.2 Global Radiopharmaceutical Therapy Revenue Market Share by Manufacturers (2019-2024)
3.3 Radiopharmaceutical Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Radiopharmaceutical Therapy Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Radiopharmaceutical Therapy Sales Sites, Area Served, Product Type
3.6 Radiopharmaceutical Therapy Market Competitive Situation and Trends
3.6.1 Radiopharmaceutical Therapy Market Concentration Rate
3.6.2 Global 5 and 10 Largest Radiopharmaceutical Therapy Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 RADIOPHARMACEUTICAL THERAPY INDUSTRY CHAIN ANALYSIS
4.1 Radiopharmaceutical Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF RADIOPHARMACEUTICAL THERAPY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 RADIOPHARMACEUTICAL THERAPY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Radiopharmaceutical Therapy Sales Market Share by Type (2019-2024)
6.3 Global Radiopharmaceutical Therapy Market Size Market Share by Type (2019-2024)
6.4 Global Radiopharmaceutical Therapy Price by Type (2019-2024)
7 RADIOPHARMACEUTICAL THERAPY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Radiopharmaceutical Therapy Market Sales by Application (2019-2024)
7.3 Global Radiopharmaceutical Therapy Market Size (M USD) by Application (2019-2024)
7.4 Global Radiopharmaceutical Therapy Sales Growth Rate by Application (2019-2024)
8 RADIOPHARMACEUTICAL THERAPY MARKET SEGMENTATION BY REGION
8.1 Global Radiopharmaceutical Therapy Sales by Region
8.1.1 Global Radiopharmaceutical Therapy Sales by Region
8.1.2 Global Radiopharmaceutical Therapy Sales Market Share by Region
8.2 North America
8.2.1 North America Radiopharmaceutical Therapy Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Radiopharmaceutical Therapy Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Radiopharmaceutical Therapy Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Radiopharmaceutical Therapy Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Radiopharmaceutical Therapy Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Bracco Imaging
9.1.1 Bracco Imaging Radiopharmaceutical Therapy Basic Information
9.1.2 Bracco Imaging Radiopharmaceutical Therapy Product Overview
9.1.3 Bracco Imaging Radiopharmaceutical Therapy Product Market Performance
9.1.4 Bracco Imaging Business Overview
9.1.5 Bracco Imaging Radiopharmaceutical Therapy SWOT Analysis
9.1.6 Bracco Imaging Recent Developments
9.2 Bayer
9.2.1 Bayer Radiopharmaceutical Therapy Basic Information
9.2.2 Bayer Radiopharmaceutical Therapy Product Overview
9.2.3 Bayer Radiopharmaceutical Therapy Product Market Performance
9.2.4 Bayer Business Overview
9.2.5 Bayer Radiopharmaceutical Therapy SWOT Analysis
9.2.6 Bayer Recent Developments
9.3 Mallinckrodt
9.3.1 Mallinckrodt Radiopharmaceutical Therapy Basic Information
9.3.2 Mallinckrodt Radiopharmaceutical Therapy Product Overview
9.3.3 Mallinckrodt Radiopharmaceutical Therapy Product Market Performance
9.3.4 Mallinckrodt Radiopharmaceutical Therapy SWOT Analysis
9.3.5 Mallinckrodt Business Overview
9.3.6 Mallinckrodt Recent Developments
9.4 Nordion
9.4.1 Nordion Radiopharmaceutical Therapy Basic Information
9.4.2 Nordion Radiopharmaceutical Therapy Product Overview
9.4.3 Nordion Radiopharmaceutical Therapy Product Market Performance
9.4.4 Nordion Business Overview
9.4.5 Nordion Recent Developments
9.5 Triad Isotopes
9.5.1 Triad Isotopes Radiopharmaceutical Therapy Basic Information
9.5.2 Triad Isotopes Radiopharmaceutical Therapy Product Overview
9.5.3 Triad Isotopes Radiopharmaceutical Therapy Product Market Performance
9.5.4 Triad Isotopes Business Overview
9.5.5 Triad Isotopes Recent Developments
9.6 Lantheus
9.6.1 Lantheus Radiopharmaceutical Therapy Basic Information
9.6.2 Lantheus Radiopharmaceutical Therapy Product Overview
9.6.3 Lantheus Radiopharmaceutical Therapy Product Market Performance
9.6.4 Lantheus Business Overview
9.6.5 Lantheus Recent Developments
9.7 IBA Group
9.7.1 IBA Group Radiopharmaceutical Therapy Basic Information
9.7.2 IBA Group Radiopharmaceutical Therapy Product Overview
9.7.3 IBA Group Radiopharmaceutical Therapy Product Market Performance
9.7.4 IBA Group Business Overview
9.7.5 IBA Group Recent Developments
9.8 GE Healthcare
9.8.1 GE Healthcare Radiopharmaceutical Therapy Basic Information
9.8.2 GE Healthcare Radiopharmaceutical Therapy Product Overview
9.8.3 GE Healthcare Radiopharmaceutical Therapy Product Market Performance
9.8.4 GE Healthcare Business Overview
9.8.5 GE Healthcare Recent Developments
9.9 China Isotope and Radiation
9.9.1 China Isotope and Radiation Radiopharmaceutical Therapy Basic Information
9.9.2 China Isotope and Radiation Radiopharmaceutical Therapy Product Overview
9.9.3 China Isotope and Radiation Radiopharmaceutical Therapy Product Market Performance
9.9.4 China Isotope and Radiation Business Overview
9.9.5 China Isotope and Radiation Recent Developments
9.10 Jubilant Pharma
9.10.1 Jubilant Pharma Radiopharmaceutical Therapy Basic Information
9.10.2 Jubilant Pharma Radiopharmaceutical Therapy Product Overview
9.10.3 Jubilant Pharma Radiopharmaceutical Therapy Product Market Performance
9.10.4 Jubilant Pharma Business Overview
9.10.5 Jubilant Pharma Recent Developments
9.11 Eli Lilly
9.11.1 Eli Lilly Radiopharmaceutical Therapy Basic Information
9.11.2 Eli Lilly Radiopharmaceutical Therapy Product Overview
9.11.3 Eli Lilly Radiopharmaceutical Therapy Product Market Performance
9.11.4 Eli Lilly Business Overview
9.11.5 Eli Lilly Recent Developments
9.12 Advanced Accelerator Applications
9.12.1 Advanced Accelerator Applications Radiopharmaceutical Therapy Basic Information
9.12.2 Advanced Accelerator Applications Radiopharmaceutical Therapy Product Overview
9.12.3 Advanced Accelerator Applications Radiopharmaceutical Therapy Product Market Performance
9.12.4 Advanced Accelerator Applications Business Overview
9.12.5 Advanced Accelerator Applications Recent Developments
9.13 SIEMENS
9.13.1 SIEMENS Radiopharmaceutical Therapy Basic Information
9.13.2 SIEMENS Radiopharmaceutical Therapy Product Overview
9.13.3 SIEMENS Radiopharmaceutical Therapy Product Market Performance
9.13.4 SIEMENS Business Overview
9.13.5 SIEMENS Recent Developments
9.14 Dongcheng
9.14.1 Dongcheng Radiopharmaceutical Therapy Basic Information
9.14.2 Dongcheng Radiopharmaceutical Therapy Product Overview
9.14.3 Dongcheng Radiopharmaceutical Therapy Product Market Performance
9.14.4 Dongcheng Business Overview
9.14.5 Dongcheng Recent Developments
9.15 Navidea
9.15.1 Navidea Radiopharmaceutical Therapy Basic Information
9.15.2 Navidea Radiopharmaceutical Therapy Product Overview
9.15.3 Navidea Radiopharmaceutical Therapy Product Market Performance
9.15.4 Navidea Business Overview
9.15.5 Navidea Recent Developments
10 RADIOPHARMACEUTICAL THERAPY MARKET FORECAST BY REGION
10.1 Global Radiopharmaceutical Therapy Market Size Forecast
10.2 Global Radiopharmaceutical Therapy Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Radiopharmaceutical Therapy Market Size Forecast by Country
10.2.3 Asia Pacific Radiopharmaceutical Therapy Market Size Forecast by Region
10.2.4 South America Radiopharmaceutical Therapy Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Radiopharmaceutical Therapy by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Radiopharmaceutical Therapy Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Radiopharmaceutical Therapy by Type (2025-2030)
11.1.2 Global Radiopharmaceutical Therapy Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Radiopharmaceutical Therapy by Type (2025-2030)
11.2 Global Radiopharmaceutical Therapy Market Forecast by Application (2025-2030)
11.2.1 Global Radiopharmaceutical Therapy Sales (Kilotons) Forecast by Application
11.2.2 Global Radiopharmaceutical Therapy Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Radiopharmaceutical Therapy Market Size Comparison by Region (M USD)
Table 5. Global Radiopharmaceutical Therapy Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Radiopharmaceutical Therapy Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Radiopharmaceutical Therapy Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Radiopharmaceutical Therapy Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiopharmaceutical Therapy as of 2022)
Table 10. Global Market Radiopharmaceutical Therapy Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Radiopharmaceutical Therapy Sales Sites and Area Served
Table 12. Manufacturers Radiopharmaceutical Therapy Product Type
Table 13. Global Radiopharmaceutical Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Radiopharmaceutical Therapy
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Radiopharmaceutical Therapy Market Challenges
Table 22. Global Radiopharmaceutical Therapy Sales by Type (Kilotons)
Table 23. Global Radiopharmaceutical Therapy Market Size by Type (M USD)
Table 24. Global Radiopharmaceutical Therapy Sales (Kilotons) by Type (2019-2024)
Table 25. Global Radiopharmaceutical Therapy Sales Market Share by Type (2019-2024)
Table 26. Global Radiopharmaceutical Therapy Market Size (M USD) by Type (2019-2024)
Table 27. Global Radiopharmaceutical Therapy Market Size Share by Type (2019-2024)
Table 28. Global Radiopharmaceutical Therapy Price (USD/Ton) by Type (2019-2024)
Table 29. Global Radiopharmaceutical Therapy Sales (Kilotons) by Application
Table 30. Global Radiopharmaceutical Therapy Market Size by Application
Table 31. Global Radiopharmaceutical Therapy Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Radiopharmaceutical Therapy Sales Market Share by Application (2019-2024)
Table 33. Global Radiopharmaceutical Therapy Sales by Application (2019-2024) & (M USD)
Table 34. Global Radiopharmaceutical Therapy Market Share by Application (2019-2024)
Table 35. Global Radiopharmaceutical Therapy Sales Growth Rate by Application (2019-2024)
Table 36. Global Radiopharmaceutical Therapy Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Radiopharmaceutical Therapy Sales Market Share by Region (2019-2024)
Table 38. North America Radiopharmaceutical Therapy Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Radiopharmaceutical Therapy Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Radiopharmaceutical Therapy Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Radiopharmaceutical Therapy Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Radiopharmaceutical Therapy Sales by Region (2019-2024) & (Kilotons)
Table 43. Bracco Imaging Radiopharmaceutical Therapy Basic Information
Table 44. Bracco Imaging Radiopharmaceutical Therapy Product Overview
Table 45. Bracco Imaging Radiopharmaceutical Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Bracco Imaging Business Overview
Table 47. Bracco Imaging Radiopharmaceutical Therapy SWOT Analysis
Table 48. Bracco Imaging Recent Developments
Table 49. Bayer Radiopharmaceutical Therapy Basic Information
Table 50. Bayer Radiopharmaceutical Therapy Product Overview
Table 51. Bayer Radiopharmaceutical Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Bayer Business Overview
Table 53. Bayer Radiopharmaceutical Therapy SWOT Analysis
Table 54. Bayer Recent Developments
Table 55. Mallinckrodt Radiopharmaceutical Therapy Basic Information
Table 56. Mallinckrodt Radiopharmaceutical Therapy Product Overview
Table 57. Mallinckrodt Radiopharmaceutical Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Mallinckrodt Radiopharmaceutical Therapy SWOT Analysis
Table 59. Mallinckrodt Business Overview
Table 60. Mallinckrodt Recent Developments
Table 61. Nordion Radiopharmaceutical Therapy Basic Information
Table 62. Nordion Radiopharmaceutical Therapy Product Overview
Table 63. Nordion Radiopharmaceutical Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Nordion Business Overview
Table 65. Nordion Recent Developments
Table 66. Triad Isotopes Radiopharmaceutical Therapy Basic Information
Table 67. Triad Isotopes Radiopharmaceutical Therapy Product Overview
Table 68. Triad Isotopes Radiopharmaceutical Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Triad Isotopes Business Overview
Table 70. Triad Isotopes Recent Developments
Table 71. Lantheus Radiopharmaceutical Therapy Basic Information
Table 72. Lantheus Radiopharmaceutical Therapy Product Overview
Table 73. Lantheus Radiopharmaceutical Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Lantheus Business Overview
Table 75. Lantheus Recent Developments
Table 76. IBA Group Radiopharmaceutical Therapy Basic Information
Table 77. IBA Group Radiopharmaceutical Therapy Product Overview
Table 78. IBA Group Radiopharmaceutical Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. IBA Group Business Overview
Table 80. IBA Group Recent Developments
Table 81. GE Healthcare Radiopharmaceutical Therapy Basic Information
Table 82. GE Healthcare Radiopharmaceutical Therapy Product Overview
Table 83. GE Healthcare Radiopharmaceutical Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. GE Healthcare Business Overview
Table 85. GE Healthcare Recent Developments
Table 86. China Isotope and Radiation Radiopharmaceutical Therapy Basic Information
Table 87. China Isotope and Radiation Radiopharmaceutical Therapy Product Overview
Table 88. China Isotope and Radiation Radiopharmaceutical Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. China Isotope and Radiation Business Overview
Table 90. China Isotope and Radiation Recent Developments
Table 91. Jubilant Pharma Radiopharmaceutical Therapy Basic Information
Table 92. Jubilant Pharma Radiopharmaceutical Therapy Product Overview
Table 93. Jubilant Pharma Radiopharmaceutical Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Jubilant Pharma Business Overview
Table 95. Jubilant Pharma Recent Developments
Table 96. Eli Lilly Radiopharmaceutical Therapy Basic Information
Table 97. Eli Lilly Radiopharmaceutical Therapy Product Overview
Table 98. Eli Lilly Radiopharmaceutical Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Eli Lilly Business Overview
Table 100. Eli Lilly Recent Developments
Table 101. Advanced Accelerator Applications Radiopharmaceutical Therapy Basic Information
Table 102. Advanced Accelerator Applications Radiopharmaceutical Therapy Product Overview
Table 103. Advanced Accelerator Applications Radiopharmaceutical Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Advanced Accelerator Applications Business Overview
Table 105. Advanced Accelerator Applications Recent Developments
Table 106. SIEMENS Radiopharmaceutical Therapy Basic Information
Table 107. SIEMENS Radiopharmaceutical Therapy Product Overview
Table 108. SIEMENS Radiopharmaceutical Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. SIEMENS Business Overview
Table 110. SIEMENS Recent Developments
Table 111. Dongcheng Radiopharmaceutical Therapy Basic Information
Table 112. Dongcheng Radiopharmaceutical Therapy Product Overview
Table 113. Dongcheng Radiopharmaceutical Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Dongcheng Business Overview
Table 115. Dongcheng Recent Developments
Table 116. Navidea Radiopharmaceutical Therapy Basic Information
Table 117. Navidea Radiopharmaceutical Therapy Product Overview
Table 118. Navidea Radiopharmaceutical Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Navidea Business Overview
Table 120. Navidea Recent Developments
Table 121. Global Radiopharmaceutical Therapy Sales Forecast by Region (2025-2030) & (Kilotons)
Table 122. Global Radiopharmaceutical Therapy Market Size Forecast by Region (2025-2030) & (M USD)
Table 123. North America Radiopharmaceutical Therapy Sales Forecast by Country (2025-2030) & (Kilotons)
Table 124. North America Radiopharmaceutical Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 125. Europe Radiopharmaceutical Therapy Sales Forecast by Country (2025-2030) & (Kilotons)
Table 126. Europe Radiopharmaceutical Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 127. Asia Pacific Radiopharmaceutical Therapy Sales Forecast by Region (2025-2030) & (Kilotons)
Table 128. Asia Pacific Radiopharmaceutical Therapy Market Size Forecast by Region (2025-2030) & (M USD)
Table 129. South America Radiopharmaceutical Therapy Sales Forecast by Country (2025-2030) & (Kilotons)
Table 130. South America Radiopharmaceutical Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 131. Middle East and Africa Radiopharmaceutical Therapy Consumption Forecast by Country (2025-2030) & (Units)
Table 132. Middle East and Africa Radiopharmaceutical Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 133. Global Radiopharmaceutical Therapy Sales Forecast by Type (2025-2030) & (Kilotons)
Table 134. Global Radiopharmaceutical Therapy Market Size Forecast by Type (2025-2030) & (M USD)
Table 135. Global Radiopharmaceutical Therapy Price Forecast by Type (2025-2030) & (USD/Ton)
Table 136. Global Radiopharmaceutical Therapy Sales (Kilotons) Forecast by Application (2025-2030)
Table 137. Global Radiopharmaceutical Therapy Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Radiopharmaceutical Therapy Market Size Comparison by Region (M USD)
Table 5. Global Radiopharmaceutical Therapy Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Radiopharmaceutical Therapy Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Radiopharmaceutical Therapy Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Radiopharmaceutical Therapy Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiopharmaceutical Therapy as of 2022)
Table 10. Global Market Radiopharmaceutical Therapy Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Radiopharmaceutical Therapy Sales Sites and Area Served
Table 12. Manufacturers Radiopharmaceutical Therapy Product Type
Table 13. Global Radiopharmaceutical Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Radiopharmaceutical Therapy
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Radiopharmaceutical Therapy Market Challenges
Table 22. Global Radiopharmaceutical Therapy Sales by Type (Kilotons)
Table 23. Global Radiopharmaceutical Therapy Market Size by Type (M USD)
Table 24. Global Radiopharmaceutical Therapy Sales (Kilotons) by Type (2019-2024)
Table 25. Global Radiopharmaceutical Therapy Sales Market Share by Type (2019-2024)
Table 26. Global Radiopharmaceutical Therapy Market Size (M USD) by Type (2019-2024)
Table 27. Global Radiopharmaceutical Therapy Market Size Share by Type (2019-2024)
Table 28. Global Radiopharmaceutical Therapy Price (USD/Ton) by Type (2019-2024)
Table 29. Global Radiopharmaceutical Therapy Sales (Kilotons) by Application
Table 30. Global Radiopharmaceutical Therapy Market Size by Application
Table 31. Global Radiopharmaceutical Therapy Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Radiopharmaceutical Therapy Sales Market Share by Application (2019-2024)
Table 33. Global Radiopharmaceutical Therapy Sales by Application (2019-2024) & (M USD)
Table 34. Global Radiopharmaceutical Therapy Market Share by Application (2019-2024)
Table 35. Global Radiopharmaceutical Therapy Sales Growth Rate by Application (2019-2024)
Table 36. Global Radiopharmaceutical Therapy Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Radiopharmaceutical Therapy Sales Market Share by Region (2019-2024)
Table 38. North America Radiopharmaceutical Therapy Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Radiopharmaceutical Therapy Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Radiopharmaceutical Therapy Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Radiopharmaceutical Therapy Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Radiopharmaceutical Therapy Sales by Region (2019-2024) & (Kilotons)
Table 43. Bracco Imaging Radiopharmaceutical Therapy Basic Information
Table 44. Bracco Imaging Radiopharmaceutical Therapy Product Overview
Table 45. Bracco Imaging Radiopharmaceutical Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Bracco Imaging Business Overview
Table 47. Bracco Imaging Radiopharmaceutical Therapy SWOT Analysis
Table 48. Bracco Imaging Recent Developments
Table 49. Bayer Radiopharmaceutical Therapy Basic Information
Table 50. Bayer Radiopharmaceutical Therapy Product Overview
Table 51. Bayer Radiopharmaceutical Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Bayer Business Overview
Table 53. Bayer Radiopharmaceutical Therapy SWOT Analysis
Table 54. Bayer Recent Developments
Table 55. Mallinckrodt Radiopharmaceutical Therapy Basic Information
Table 56. Mallinckrodt Radiopharmaceutical Therapy Product Overview
Table 57. Mallinckrodt Radiopharmaceutical Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Mallinckrodt Radiopharmaceutical Therapy SWOT Analysis
Table 59. Mallinckrodt Business Overview
Table 60. Mallinckrodt Recent Developments
Table 61. Nordion Radiopharmaceutical Therapy Basic Information
Table 62. Nordion Radiopharmaceutical Therapy Product Overview
Table 63. Nordion Radiopharmaceutical Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. Nordion Business Overview
Table 65. Nordion Recent Developments
Table 66. Triad Isotopes Radiopharmaceutical Therapy Basic Information
Table 67. Triad Isotopes Radiopharmaceutical Therapy Product Overview
Table 68. Triad Isotopes Radiopharmaceutical Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Triad Isotopes Business Overview
Table 70. Triad Isotopes Recent Developments
Table 71. Lantheus Radiopharmaceutical Therapy Basic Information
Table 72. Lantheus Radiopharmaceutical Therapy Product Overview
Table 73. Lantheus Radiopharmaceutical Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Lantheus Business Overview
Table 75. Lantheus Recent Developments
Table 76. IBA Group Radiopharmaceutical Therapy Basic Information
Table 77. IBA Group Radiopharmaceutical Therapy Product Overview
Table 78. IBA Group Radiopharmaceutical Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. IBA Group Business Overview
Table 80. IBA Group Recent Developments
Table 81. GE Healthcare Radiopharmaceutical Therapy Basic Information
Table 82. GE Healthcare Radiopharmaceutical Therapy Product Overview
Table 83. GE Healthcare Radiopharmaceutical Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. GE Healthcare Business Overview
Table 85. GE Healthcare Recent Developments
Table 86. China Isotope and Radiation Radiopharmaceutical Therapy Basic Information
Table 87. China Isotope and Radiation Radiopharmaceutical Therapy Product Overview
Table 88. China Isotope and Radiation Radiopharmaceutical Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. China Isotope and Radiation Business Overview
Table 90. China Isotope and Radiation Recent Developments
Table 91. Jubilant Pharma Radiopharmaceutical Therapy Basic Information
Table 92. Jubilant Pharma Radiopharmaceutical Therapy Product Overview
Table 93. Jubilant Pharma Radiopharmaceutical Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Jubilant Pharma Business Overview
Table 95. Jubilant Pharma Recent Developments
Table 96. Eli Lilly Radiopharmaceutical Therapy Basic Information
Table 97. Eli Lilly Radiopharmaceutical Therapy Product Overview
Table 98. Eli Lilly Radiopharmaceutical Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Eli Lilly Business Overview
Table 100. Eli Lilly Recent Developments
Table 101. Advanced Accelerator Applications Radiopharmaceutical Therapy Basic Information
Table 102. Advanced Accelerator Applications Radiopharmaceutical Therapy Product Overview
Table 103. Advanced Accelerator Applications Radiopharmaceutical Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Advanced Accelerator Applications Business Overview
Table 105. Advanced Accelerator Applications Recent Developments
Table 106. SIEMENS Radiopharmaceutical Therapy Basic Information
Table 107. SIEMENS Radiopharmaceutical Therapy Product Overview
Table 108. SIEMENS Radiopharmaceutical Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. SIEMENS Business Overview
Table 110. SIEMENS Recent Developments
Table 111. Dongcheng Radiopharmaceutical Therapy Basic Information
Table 112. Dongcheng Radiopharmaceutical Therapy Product Overview
Table 113. Dongcheng Radiopharmaceutical Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Dongcheng Business Overview
Table 115. Dongcheng Recent Developments
Table 116. Navidea Radiopharmaceutical Therapy Basic Information
Table 117. Navidea Radiopharmaceutical Therapy Product Overview
Table 118. Navidea Radiopharmaceutical Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. Navidea Business Overview
Table 120. Navidea Recent Developments
Table 121. Global Radiopharmaceutical Therapy Sales Forecast by Region (2025-2030) & (Kilotons)
Table 122. Global Radiopharmaceutical Therapy Market Size Forecast by Region (2025-2030) & (M USD)
Table 123. North America Radiopharmaceutical Therapy Sales Forecast by Country (2025-2030) & (Kilotons)
Table 124. North America Radiopharmaceutical Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 125. Europe Radiopharmaceutical Therapy Sales Forecast by Country (2025-2030) & (Kilotons)
Table 126. Europe Radiopharmaceutical Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 127. Asia Pacific Radiopharmaceutical Therapy Sales Forecast by Region (2025-2030) & (Kilotons)
Table 128. Asia Pacific Radiopharmaceutical Therapy Market Size Forecast by Region (2025-2030) & (M USD)
Table 129. South America Radiopharmaceutical Therapy Sales Forecast by Country (2025-2030) & (Kilotons)
Table 130. South America Radiopharmaceutical Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 131. Middle East and Africa Radiopharmaceutical Therapy Consumption Forecast by Country (2025-2030) & (Units)
Table 132. Middle East and Africa Radiopharmaceutical Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 133. Global Radiopharmaceutical Therapy Sales Forecast by Type (2025-2030) & (Kilotons)
Table 134. Global Radiopharmaceutical Therapy Market Size Forecast by Type (2025-2030) & (M USD)
Table 135. Global Radiopharmaceutical Therapy Price Forecast by Type (2025-2030) & (USD/Ton)
Table 136. Global Radiopharmaceutical Therapy Sales (Kilotons) Forecast by Application (2025-2030)
Table 137. Global Radiopharmaceutical Therapy Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Radiopharmaceutical Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Radiopharmaceutical Therapy Market Size (M USD), 2019-2030
Figure 5. Global Radiopharmaceutical Therapy Market Size (M USD) (2019-2030)
Figure 6. Global Radiopharmaceutical Therapy Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Radiopharmaceutical Therapy Market Size by Country (M USD)
Figure 11. Radiopharmaceutical Therapy Sales Share by Manufacturers in 2023
Figure 12. Global Radiopharmaceutical Therapy Revenue Share by Manufacturers in 2023
Figure 13. Radiopharmaceutical Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Radiopharmaceutical Therapy Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Radiopharmaceutical Therapy Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Radiopharmaceutical Therapy Market Share by Type
Figure 18. Sales Market Share of Radiopharmaceutical Therapy by Type (2019-2024)
Figure 19. Sales Market Share of Radiopharmaceutical Therapy by Type in 2023
Figure 20. Market Size Share of Radiopharmaceutical Therapy by Type (2019-2024)
Figure 21. Market Size Market Share of Radiopharmaceutical Therapy by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Radiopharmaceutical Therapy Market Share by Application
Figure 24. Global Radiopharmaceutical Therapy Sales Market Share by Application (2019-2024)
Figure 25. Global Radiopharmaceutical Therapy Sales Market Share by Application in 2023
Figure 26. Global Radiopharmaceutical Therapy Market Share by Application (2019-2024)
Figure 27. Global Radiopharmaceutical Therapy Market Share by Application in 2023
Figure 28. Global Radiopharmaceutical Therapy Sales Growth Rate by Application (2019-2024)
Figure 29. Global Radiopharmaceutical Therapy Sales Market Share by Region (2019-2024)
Figure 30. North America Radiopharmaceutical Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Radiopharmaceutical Therapy Sales Market Share by Country in 2023
Figure 32. U.S. Radiopharmaceutical Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Radiopharmaceutical Therapy Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Radiopharmaceutical Therapy Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Radiopharmaceutical Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Radiopharmaceutical Therapy Sales Market Share by Country in 2023
Figure 37. Germany Radiopharmaceutical Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Radiopharmaceutical Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Radiopharmaceutical Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Radiopharmaceutical Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Radiopharmaceutical Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Radiopharmaceutical Therapy Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Radiopharmaceutical Therapy Sales Market Share by Region in 2023
Figure 44. China Radiopharmaceutical Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Radiopharmaceutical Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Radiopharmaceutical Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Radiopharmaceutical Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Radiopharmaceutical Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Radiopharmaceutical Therapy Sales and Growth Rate (Kilotons)
Figure 50. South America Radiopharmaceutical Therapy Sales Market Share by Country in 2023
Figure 51. Brazil Radiopharmaceutical Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Radiopharmaceutical Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Radiopharmaceutical Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Radiopharmaceutical Therapy Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Radiopharmaceutical Therapy Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Radiopharmaceutical Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Radiopharmaceutical Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Radiopharmaceutical Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Radiopharmaceutical Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Radiopharmaceutical Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Radiopharmaceutical Therapy Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Radiopharmaceutical Therapy Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Radiopharmaceutical Therapy Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Radiopharmaceutical Therapy Market Share Forecast by Type (2025-2030)
Figure 65. Global Radiopharmaceutical Therapy Sales Forecast by Application (2025-2030)
Figure 66. Global Radiopharmaceutical Therapy Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Radiopharmaceutical Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Radiopharmaceutical Therapy Market Size (M USD), 2019-2030
Figure 5. Global Radiopharmaceutical Therapy Market Size (M USD) (2019-2030)
Figure 6. Global Radiopharmaceutical Therapy Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Radiopharmaceutical Therapy Market Size by Country (M USD)
Figure 11. Radiopharmaceutical Therapy Sales Share by Manufacturers in 2023
Figure 12. Global Radiopharmaceutical Therapy Revenue Share by Manufacturers in 2023
Figure 13. Radiopharmaceutical Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Radiopharmaceutical Therapy Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Radiopharmaceutical Therapy Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Radiopharmaceutical Therapy Market Share by Type
Figure 18. Sales Market Share of Radiopharmaceutical Therapy by Type (2019-2024)
Figure 19. Sales Market Share of Radiopharmaceutical Therapy by Type in 2023
Figure 20. Market Size Share of Radiopharmaceutical Therapy by Type (2019-2024)
Figure 21. Market Size Market Share of Radiopharmaceutical Therapy by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Radiopharmaceutical Therapy Market Share by Application
Figure 24. Global Radiopharmaceutical Therapy Sales Market Share by Application (2019-2024)
Figure 25. Global Radiopharmaceutical Therapy Sales Market Share by Application in 2023
Figure 26. Global Radiopharmaceutical Therapy Market Share by Application (2019-2024)
Figure 27. Global Radiopharmaceutical Therapy Market Share by Application in 2023
Figure 28. Global Radiopharmaceutical Therapy Sales Growth Rate by Application (2019-2024)
Figure 29. Global Radiopharmaceutical Therapy Sales Market Share by Region (2019-2024)
Figure 30. North America Radiopharmaceutical Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Radiopharmaceutical Therapy Sales Market Share by Country in 2023
Figure 32. U.S. Radiopharmaceutical Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Radiopharmaceutical Therapy Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Radiopharmaceutical Therapy Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Radiopharmaceutical Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Radiopharmaceutical Therapy Sales Market Share by Country in 2023
Figure 37. Germany Radiopharmaceutical Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Radiopharmaceutical Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Radiopharmaceutical Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Radiopharmaceutical Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Radiopharmaceutical Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Radiopharmaceutical Therapy Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Radiopharmaceutical Therapy Sales Market Share by Region in 2023
Figure 44. China Radiopharmaceutical Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Radiopharmaceutical Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Radiopharmaceutical Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Radiopharmaceutical Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Radiopharmaceutical Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Radiopharmaceutical Therapy Sales and Growth Rate (Kilotons)
Figure 50. South America Radiopharmaceutical Therapy Sales Market Share by Country in 2023
Figure 51. Brazil Radiopharmaceutical Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Radiopharmaceutical Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Radiopharmaceutical Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Radiopharmaceutical Therapy Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Radiopharmaceutical Therapy Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Radiopharmaceutical Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Radiopharmaceutical Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Radiopharmaceutical Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Radiopharmaceutical Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Radiopharmaceutical Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Radiopharmaceutical Therapy Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Radiopharmaceutical Therapy Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Radiopharmaceutical Therapy Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Radiopharmaceutical Therapy Market Share Forecast by Type (2025-2030)
Figure 65. Global Radiopharmaceutical Therapy Sales Forecast by Application (2025-2030)
Figure 66. Global Radiopharmaceutical Therapy Market Share Forecast by Application (2025-2030)
